Suzhou QuanXinMeizhi Intelligent Technology Co., Ltd. is a high-tech enterprise deeply engaged in artificial intelligence and large model technology, specializing in the research, development, production, and sales of intelligent medical equipment. The company closely follows clinical needs, empowers physicians with AI for precise diagnosis and treatment, relies on medical large models to customize personalized solutions for patients, and assists hospitals in building an AI-driven integrated smart diagnosis and treatment platform, effectively optimizing medical resource allocation and alleviating medical difficulties.

The core product, the Temporomandibular Joint Intelligent Rehabilitation System (registration number: Su Xian Zhu Zhuan 20262190823), is currently the only legally marketed intelligent rehabilitation system in the field of temporomandibular joint mouth opening training globally. This product fills the gap in the global legal application of this field, enabling quantified and safe passive training for patients at home, significantly improving rehabilitation outcomes and compliance; at the same time, it greatly reduces the burden of manual guidance by medical staff, effectively promoting tiered diagnosis and treatment and standardization of oral rehabilitation. As a benchmark for domestic high-end rehabilitation equipment, its advent not only reduces dependence on imports but also lays a solid foundation for “China’s intelligent manufacturing” to go global, possessing significant clinical value and social significance.

Relying on profound technical accumulation, the company has transformed artificial intelligence algorithms, medical large models, multi-modal perception, and intelligent data analysis into core self-research capabilities, establishing a widely-covered and highly adaptable intelligent medical product system. Its products and integrated AI platform are widely used in fields such as cosmetic surgery, dentistry, and otolaryngology and head and neck surgery, laying a solid technical foundation for the intelligent and digital construction of hospitals in the future with full-stack solutions.

In terms of market layout, the company adheres to the strategy of “Rooted in China, Looking to the World”. In the domestic market, it has won high recognition from medical institutions with its excellent product performance and comprehensive service system. In terms of overseas expansion, the company focuses on the core regions of Southeast Asia and has conducted clinical trials in top hospitals in Thailand, Indonesia, and other countries, steadily advancing product adaptation and market access, and accelerating the construction of a global medical science and technology innovation service system.

Looking ahead, QuanXinMeizhi will adhere to the concept of “creating with thought, establishing with diligence, basing on precision, and surpassing with intelligence”. With “AI+ medical big model” as the core engine, the company will continue to optimize the cloud management platform, break down data barriers, and enhance the efficiency of diagnosis and treatment collaboration. The company will deeply cultivate its domestic market and expand overseas, striving to rank among the forefront of the global intelligent medical equipment industry. It will use top-notch scientific and technological innovation to safeguard public health and promote the medical industry towards intelligence, precision, and efficiency.